Myeloproliferative Disorders
Showing NaN - NaN of 8
Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford
Recruiting
- Allogeneic Hematopoietic Cell Transplantation (HCT)
- +5 more
- Purified regulatory T-cells (Treg) plus CD34+ HSPC
- +7 more
-
Stanford, CaliforniaStanford University
Oct 28, 2021
Dysregulated Signaling in MPD Via Multiparameter
Terminated
- Myeloproliferative Disorders
- Myeloproliferative Disorders (MPD)
-
Stanford, CaliforniaStanford University School of Medicine
Apr 7, 2020
Neural Tube Defects, Anemia, Leukemia, Myeloid Trial in Stanford (CIK cells, Cyclosporine, Mycophenolate Mofetil)
Completed
- Neural Tube Defects
- +5 more
- CIK cells
- +4 more
-
Stanford, CaliforniaStanford University School of Medicine
Apr 18, 2019
Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic
Completed
- Leukemia
- +2 more
- Allogeneic bone marrow transplantation
- Peripheral blood stem cell transplantation
-
Birmingham, Alabama
- +44 more
Oct 24, 2017
B-Receptor Signaling in Cardiomyopathy
Completed
- Carcinomas
- +37 more
-
Stanford, CaliforniaStanford University School of Medicine
Nov 16, 2015
Myeloproliferative Disorders, Blood Cancer, MDS Trial in Stanford (Total Lymphoid Irradiation (TLI), Anti-Thymocyte Globulin as
Completed
- Myeloproliferative Disorders
- +2 more
- Total Lymphoid Irradiation (TLI)
- Anti-Thymocyte Globulin as Conditioning (ATG)
-
Stanford, CaliforniaStanford University School of Medicine
Mar 16, 2015
Acute Disease, MDS, Leukemia, Myeloid, Chronic Trial in Stanford (ablative allogeneic hematopoietic cell transplantation)
Completed
- Acute Disease
- +6 more
- ablative allogeneic hematopoietic cell transplantation
-
Stanford, CaliforniaStanford University School of Medicine
Dec 13, 2012
MDS, Myeloproliferative Disorders, Blood and Marrow Transplant (BMT) Trial in Stanford (nonmyeloablative allogeneic
Completed
- Myelodysplastic Syndromes
- +4 more
- nonmyeloablative allogeneic hematopoietic cell transplant
-
Stanford, CaliforniaStanford University School of Medicine
Oct 13, 2010